Renal Cancer - Results from #2400

Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier. December 5, 2020

Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States. December 4, 2020

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma. December 4, 2020

To Stage or Not to Stage: Determining the True Clinical Significance of the Biopsy Tract Through Perinephric Fat in Assessing Renal Cell Carcinoma. December 4, 2020

Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma. December 3, 2020

Spontaneous Regression of Delayed Pulmonary and Mediastinal Metastases from Clear Cell Renal Cell Carcinoma. December 3, 2020

SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma. December 3, 2020

An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC). December 2, 2020

Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers. December 2, 2020

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program. December 2, 2020

Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma. December 1, 2020

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis. December 1, 2020

Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma. December 1, 2020

Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis. November 30, 2020

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial. November 30, 2020

A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. November 30, 2020

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan. November 27, 2020

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. November 27, 2020

A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. November 27, 2020

Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. November 26, 2020

Page 121 of 460